Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Newly Synthesized Fluorinated Cinnamylpiperazines Possessing Low In Vitro MAO-B Binding
oleh: Ivana I. Jevtić, Thu Hang Lai, Jelena Z. Penjišević, Sladjana Dukić-Stefanović, Deana B. Andrić, Peter Brust, Sladjana V. Kostić-Rajačić, Rodrigo Teodoro
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2020-10-01 |
Deskripsi
Herein, we report on the synthesis and pharmacological evaluation of ten novel fluorinated cinnamylpiperazines as potential monoamine oxidase B (MAO-B) ligands. The designed derivatives consist of either cinnamyl or 2-fluorocinnamyl moieties connected to 2-fluoropyridylpiperazines. The three-step synthesis starting from commercially available piperazine afforded the final products in overall yields between 9% and 29%. An in vitro competitive binding assay using <span style="font-variant: small-caps;">l</span>-[<sup>3</sup>H]Deprenyl as radioligand was developed and the MAO-B binding affinities of the synthesized derivatives were assessed. Docking studies revealed that the compounds <b>8</b>–<b>17</b> were stabilized in both MAO-B entrance and substrate cavities, thus resembling the binding pose of <span style="font-variant: small-caps;">l</span>-Deprenyl. Although our results revealed that the novel fluorinated cinnamylpiperazines <b>8</b>–<b>17</b> do not possess sufficient MAO-B binding affinity to be eligible as positron emission tomography (PET) agents, the herein developed binding assay and the insights gained within our docking studies will certainly pave the way for further development of MAO-B ligands.